
Hubei Aoks Bio-tech, a chemical company based in Wuhan, China, along with its director and three senior employees, faces a 13-count indictment by a U.S. federal grand jury. The charges allege the company and individuals manufactured and exported xylazine— a drug dubbed 'flesh-eating zombie drug' for its side effects— and fentanyl precursor chemicals.